glp-1 agonist alternatives to ozempic FDA approves Foundayo, an oral alternative Wegovy and GLP-1 Alternatives to Ozempic: Clinical

Ravi Rao April 8, 2026 GLP-1 receptor agonists, widely used for type 2 diabetes and weight management, often cause gastrointestinal side effects that clinicians must address proactively

What Willow actually dispenses compounded, not FDA-approved branded This is the substantive medication question and it matters before signing up anywhere

And this is where its really important to know where these patients came from

What if I am currently on brand-name Ozempic or Wegovy

With cardiovascular diseases being a leading cause of death globally, this presents a significant opportunity for market expansion

But many questions remain including its long-term safety profile, effect on lean body mass and bone mineral density, real-world tolerability, and ultimate UK pricing once and if MHRA approval is granted